
Jeffrey T. Palenik
Examiner (ID: 8947, Phone: (571)270-1966 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 1192 |
| Issued Applications | 644 |
| Pending Applications | 99 |
| Abandoned Applications | 467 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17355208
[patent_doc_number] => 20220016004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => ANTIPERSPIRANT OR DEODORANT COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/293610
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293610
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293610 | ANTIPERSPIRANT OR DEODORANT COMPOSITION | Jan 15, 2020 | Abandoned |
Array
(
[id] => 17472575
[patent_doc_number] => 20220080079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => FLUORAPATITE-CONTAINING STRUCTURES STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH
[patent_app_type] => utility
[patent_app_number] => 17/420589
[patent_app_country] => US
[patent_app_date] => 2020-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17420589
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/420589 | FLUORAPATITE-CONTAINING STRUCTURES STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH | Jan 8, 2020 | Pending |
Array
(
[id] => 17426770
[patent_doc_number] => 20220054478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => MINIMIZATION OF SYSTEMIC INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 17/420300
[patent_app_country] => US
[patent_app_date] => 2020-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17420300
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/420300 | MINIMIZATION OF SYSTEMIC INFLAMMATION | Jan 2, 2020 | Pending |
Array
(
[id] => 16963089
[patent_doc_number] => 20210214588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => LAMINATED ADHESIVE SHEET FOR SKIN
[patent_app_type] => utility
[patent_app_number] => 17/059845
[patent_app_country] => US
[patent_app_date] => 2019-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059845
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/059845 | LAMINATED ADHESIVE SHEET FOR SKIN | Dec 26, 2019 | Abandoned |
Array
(
[id] => 19410581
[patent_doc_number] => 12076373
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-03
[patent_title] => Formulations for oral administration of active agents
[patent_app_type] => utility
[patent_app_number] => 16/724400
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 31579
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16724400
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/724400 | Formulations for oral administration of active agents | Dec 22, 2019 | Issued |
Array
(
[id] => 15861237
[patent_doc_number] => 20200138022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => SELF INDICATING ANTIMICROBIAL CHEMISTRY
[patent_app_type] => utility
[patent_app_number] => 16/723486
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16723486
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/723486 | Self indicating antimicrobial chemistry | Dec 19, 2019 | Issued |
Array
(
[id] => 16197371
[patent_doc_number] => 10722507
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-28
[patent_title] => Multi-phase delivery compositions and products incorporating such compositions
[patent_app_type] => utility
[patent_app_number] => 16/718562
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 13115
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16718562
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/718562 | Multi-phase delivery compositions and products incorporating such compositions | Dec 17, 2019 | Issued |
Array
(
[id] => 20547525
[patent_doc_number] => 12558297
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-24
[patent_title] => Consumer product with controlled release, biodegradable core-shell microcapsule compositions
[patent_app_type] => utility
[patent_app_number] => 17/602073
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30712
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602073
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/602073 | Consumer product with controlled release, biodegradable core-shell microcapsule compositions | Dec 16, 2019 | Issued |
Array
(
[id] => 20882424
[patent_doc_number] => 12698459
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-08-04
[patent_title] => Controlled release, biodegradable core-shell microcapsule compositions
[patent_app_type] => utility
[patent_app_number] => 17/602032
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24025
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/602032 | CONTROLLED RELEASE, BIODEGRADABLE CORE-SHELL MICROCAPSULE COMPOSITIONS | Dec 16, 2019 | Pending |
Array
(
[id] => 16052885
[patent_doc_number] => 20200188297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => LXR Agonist in Topical Ophthalmic Formulation for Treatment of Dry-Eye Disorder
[patent_app_type] => utility
[patent_app_number] => 16/711646
[patent_app_country] => US
[patent_app_date] => 2019-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16711646
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/711646 | LXR Agonist in Topical Ophthalmic Formulation for Treatment of Dry-Eye Disorder | Dec 11, 2019 | Abandoned |
Array
(
[id] => 15765781
[patent_doc_number] => 20200113908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => COMPOSITIONS AND METHODS OF USE OF CIS-4-[2-{[(3S,4R)-3-FLUOROOXAN-4-YL]AMINO}-8-(2,4,6-TRICHLOROANILINO)-9H-PURIN-9-YL]-1-METHYLCYCLOHEXANE-1-CARBOXAMIDE
[patent_app_type] => utility
[patent_app_number] => 16/710533
[patent_app_country] => US
[patent_app_date] => 2019-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16710533
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/710533 | Compositions and methods of use of cis-4-[2-{[3S,4R)-3-fluorooxan-4-yl]amino}8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide | Dec 10, 2019 | Issued |
Array
(
[id] => 15974447
[patent_doc_number] => 10667521
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Antimicrobial material comprising synergistic combinations of metal oxides
[patent_app_type] => utility
[patent_app_number] => 16/703342
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 19586
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16703342
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/703342 | Antimicrobial material comprising synergistic combinations of metal oxides | Dec 3, 2019 | Issued |
Array
(
[id] => 17355401
[patent_doc_number] => 20220016197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => ZINGIBER ZERUMBET EXTRACT FOR COMBATING DANDRUFF
[patent_app_type] => utility
[patent_app_number] => 17/295993
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295993
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/295993 | ZINGIBER ZERUMBET EXTRACT FOR COMBATING DANDRUFF | Dec 3, 2019 | Abandoned |
Array
(
[id] => 15990123
[patent_doc_number] => 20200170932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => EXTENDED RELEASE L-TRI-IODOTHYRONINE SAFELY NORMALIZES KEY ELEMENTS OF MOLECULAR PATHOLOGY IN ALZHEIMERS DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/702067
[patent_app_country] => US
[patent_app_date] => 2019-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9867
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16702067
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/702067 | EXTENDED RELEASE L-TRI-IODOTHYRONINE SAFELY NORMALIZES KEY ELEMENTS OF MOLECULAR PATHOLOGY IN ALZHEIMERS DISEASE | Dec 2, 2019 | Abandoned |
Array
(
[id] => 15707521
[patent_doc_number] => 20200100526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => Composition and Method for Reducing or Treating Oral Inflammation
[patent_app_type] => utility
[patent_app_number] => 16/700204
[patent_app_country] => US
[patent_app_date] => 2019-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6549
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16700204
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/700204 | Composition and method for reducing or treating oral inflammation | Dec 1, 2019 | Issued |
Array
(
[id] => 17334399
[patent_doc_number] => 20220000730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => CLAY MASK COMPOSITION AND METHOD FOR USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/291268
[patent_app_country] => US
[patent_app_date] => 2019-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291268
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/291268 | CLAY MASK COMPOSITION AND METHOD FOR USING THE SAME | Nov 27, 2019 | Abandoned |
Array
(
[id] => 16852779
[patent_doc_number] => 20210153524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => Drinking Formulation for Maintaining Urinary Tract Health in Cats
[patent_app_type] => utility
[patent_app_number] => 16/697778
[patent_app_country] => US
[patent_app_date] => 2019-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16697778
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/697778 | Drinking Formulation for Maintaining Urinary Tract Health in Cats | Nov 26, 2019 | Abandoned |
Array
(
[id] => 17342057
[patent_doc_number] => 20220008388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => COMBINATION OF GABOXADOL AND LITHIUM FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/295870
[patent_app_country] => US
[patent_app_date] => 2019-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24208
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295870
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/295870 | COMBINATION OF GABOXADOL AND LITHIUM FOR THE TREATMENT OF PSYCHIATRIC DISORDERS | Nov 20, 2019 | Abandoned |
Array
(
[id] => 20848684
[patent_doc_number] => 12685701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-21
[patent_title] => Cosmetic make-up composition with long-lasting skin-perfecting effect
[patent_app_type] => utility
[patent_app_number] => 17/295571
[patent_app_country] => US
[patent_app_date] => 2019-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2545
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295571
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/295571 | COSMETIC MAKE-UP COMPOSITION WITH LONG-LASTING SKIN-PERFECTING EFFECT | Nov 19, 2019 | Issued |
Array
(
[id] => 16052833
[patent_doc_number] => 20200188271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => SPRAYABLE COSMETIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/689626
[patent_app_country] => US
[patent_app_date] => 2019-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16689626
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/689626 | SPRAYABLE COSMETIC COMPOSITION | Nov 19, 2019 | Abandoned |